FYN and breast carcinoma: It has been demonstrated that FYN enhances NOTCH2 activation in basal breast cancer cells through STAT5-mediated upregulation of Jagged-1 and DLL4 NOTCH ligands, thereby contributing to the mesenchymal phenotype.